Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Intarcia Therapeutics
MedTech
FDA panel nixes Intarcia's twice-rejected diabetes drug implant
The third time held no charm for Intarcia Therapeutics, which saw its long road through the FDA potentially forced down another detour.
Conor Hale
Sep 22, 2023 2:51pm
Sanofi finds new R&D head—Chutes & Ladders
Sep 1, 2023 9:30am
FDA once again rejects Intarcia's 6-month diabetes drug implant
Mar 11, 2020 10:32am
Longtime Novartis exec takes the helm at Macrolide Pharma
Apr 2, 2018 10:36am
Intarcia cuts 60 jobs, halts 2 late-stage trials
Feb 5, 2018 10:15am
Cullinan bags $150M to build broad slate of cancer assets
Oct 3, 2017 6:00am
